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The central venous catheter is a valuable tool in inpatient
medicine. However, with its use comes the risk of local
and systemic infections. Kluger et al estimated that
250,000 cases of central line-associated blood stream
infections occur annually. Mortality rates range from 1225% per infection.1 Therefore, it is essential that health
care providers take all necessary precautionary measures
to avoid infection. Guidelines have been published by the
Centers for Disease Control and Prevention to provide
an evidence-based medicine (EBM) approach for
avoiding central venous catheter-related infections.
Recommendations include proper skin cleansing, the use
of maximal sterile barriers, selection of the subclavian site,
avoiding routine replacement of central venous catheters,
and using antiseptic/antibiotic impregnated catheters.
Aseptic technique is the first step in infection prevention.
The patient’s skin must be properly disinfected, prior to
the insertion of any venous catheter. Typically, povidone
iodine is used for skin antisepsis. However, Maki et al
demonstrated a lower incidence of bacteremia with the
use of 2 % chlorhexidine gluconate, versus 10% povidoneiodine or 70% alcohol (0.5 versus 2.3 and 2.6 per 100
catheters, respectively).2 Furthermore, Chaiyakunapruk et
al performed a meta-analysis which showed a 50% overall
reduction in catheter-related blood stream infections with
the use of chlorhexidine.3
Once the skin has been properly disinfected, the
practitioner must take additional measures to maintain
sterile conditions. The use of sterile gloves and drapes
alone are not enough. A study done in 1994 by Raad et
al showed that using maximal sterile barrier precautions
(a cap, gown, sterile gown, sterile gloves and a large sterile
drape) substantially reduced catheter-related bloodstream
infections, as opposed to standard precautions with only
sterile gloves and small drapes.4
The site of the central venous catheter has also been
linked to infection. Collignon et al found that the lowest
rate of catheter colonization occurred with placement at
the subclavian site, and the highest rate with catheters at
the femoral site (15% vs 34%, respectively).5 Femoral
catheters have also been associated with a higher risk for
deep venous thrombosis (DVT). Therefore, from an
EBM standpoint, the subclavian vein is the preferred site

of insertion for infection control purposes. Note that all
factors must be taken into account when selecting a
catheter site in a given patient, including operator skill,
the potential for mechanical complication, patient
comfort, anatomic variables, and bleeding diatheses.
Once the central venous catheter has been placed using
proper aseptic technique, it should not be changed on a
scheduled basis. Cobb et al conducted a randomized
controlled trial where 160 patients underwent one of
four methods of catheter exchange: replacement every
three days by insertion at a new site (group 1); exchange
over a guidewire every three days (group 2); replacement
when clinically indicated by insertion at a new site
(group 3); exchange over a guidewire when clinically
indicated (group 4). The incidence rates of bloodstream
infection per 1000 days of catheter use were 3 in group
1, 6 in group 2, 2 in group 3, and 3 in group 4. Therefore
careful clinical inspection of that catheter site at least
every other day is recommended versus prophylactic
changes of catheter site.6 The exception to this is the
Swan-Ganz catheter, which should be removed within 35 days and replaced at a new site if further monitoring is
required. When changing a central venous catheter is
clinically indicated, options include changing over a
guidewire or insertion at a new site. For infection control
purposes, placement at a clean site is preferred. However,
this method is associated with a greater incidence of
mechanical complications.
Lastly, the type of catheter used has been shown to affect
the rate of infection. There is a higher incidence of
infectious complications with multi-lumen catheters.
Studies have also been done with antiseptic and
antibiotic impregnated catheters. A meta-analysis by
Veenstra et al showed a decrease in catheter colonization
and catheter-related bloodstream infections with
chlorhexidine/silver sulfadiazine-impregnated catheters,
versus non-impregnated catheters.7 Reductions in
bacteremia
have
also
been
noted
with
minocycline/rifampin-impregnated catheters.8 The
chlorhexidine/silver sulfadiazine impregnated catheters
were also more cost effective.9 Currently, the CDC
recommends implementing a comprehensive strategy to
lower the incidence of catheter related bloodstream
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infections (CRBSI), including education of practitioners,
use of maximal barrier protection, and 2% chlorhexidine
for skin antisepsis. If the CRBSI rate remains above the
institutions goal despite these measures, then
antibiotic/antiseptic impregnated catheters should be
used in adult patients in whom the central venous
catheter is expected to remain in place for >5 days.
Central venous catheter infections remain a prevalent
problem in inpatient medicine. While risk of infection is
always present with indwelling lines, measures can be
taken to minimize this potentially fatal complication.
Proper aseptic technique with thorough skin preparation
and maximal barrier precautions, careful site selection,
and diligent clinical inspection of a catheter site can
drastically reduce infection risk and improve patient care.
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